Aquestive Therapeutics (AQST) Leases (2019 - 2025)
Historic Leases for Aquestive Therapeutics (AQST) over the last 7 years, with Q3 2025 value amounting to $4.8 million.
- Aquestive Therapeutics' Leases fell 1018.83% to $4.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.8 million, marking a year-over-year decrease of 1018.83%. This contributed to the annual value of $5.2 million for FY2024, which is 674.82% down from last year.
- According to the latest figures from Q3 2025, Aquestive Therapeutics' Leases is $4.8 million, which was down 1018.83% from $4.9 million recorded in Q2 2025.
- In the past 5 years, Aquestive Therapeutics' Leases registered a high of $5.9 million during Q1 2023, and its lowest value of $2.1 million during Q3 2022.
- For the 5-year period, Aquestive Therapeutics' Leases averaged around $4.4 million, with its median value being $5.0 million (2025).
- Per our database at Business Quant, Aquestive Therapeutics' Leases plummeted by 2821.39% in 2022 and then skyrocketed by 17072.59% in 2023.
- Quarter analysis of 5 years shows Aquestive Therapeutics' Leases stood at $2.7 million in 2021, then skyrocketed by 91.23% to $5.2 million in 2022, then grew by 6.64% to $5.6 million in 2023, then fell by 6.75% to $5.2 million in 2024, then decreased by 7.97% to $4.8 million in 2025.
- Its Leases stands at $4.8 million for Q3 2025, versus $4.9 million for Q2 2025 and $5.0 million for Q1 2025.